TY  - GEN
AU  - Ali,Dina
AU  - Jönsson-Videsäter,Kerstin
AU  - Deneberg,Stefan
AU  - Bengtzén,Sofia
AU  - Nahi,Hareth
AU  - Paul,Christer
AU  - Lehmann,Sören
TI  - APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells
SN  - 1600-0609
PY  - 2011///0331
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Aza Compounds
KW  - Base Sequence
KW  - Bridged Bicyclo Compounds, Heterocyclic
KW  - Cytarabine
KW  - DNA Primers
KW  - genetics
KW  - Daunorubicin
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Female
KW  - Gene Expression
KW  - drug effects
KW  - Genes, p53
KW  - Humans
KW  - Karyotyping
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Mutation
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - metabolism
KW  - Tumor Cells, Cultured
KW  - Tumor Suppressor Protein p14ARF
KW  - Vidarabine
KW  - bcl-2-Associated X Protein
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1600-0609.2010.01557.x
ER  -